CrossBay Medical, Inc. announces FDA, Health Canada, and CE mark marketing authorizations for SonoSure SonoHysterography and Endometrial Sampling Device

News provided by

CrossBay Medical, Inc.

25 Apr, 2014, 11:39 ET

SAN RAFAEL, Calif., April 25, 2014 /PRNewswire/ -- CrossBay Medical, Inc., today announced the United States Food and Drug Administration (FDA) clearance of its product, the SonoSure™ Sonohysterography and Endometrial Sampling Device. The device has also received Health Canada clearance and the CE mark. The SonoSure™ is indicated for use to access the uterine cavity for saline infusion sonohysterography and to obtain endometrial biopsy, if indicated, utilizing the same device.

Continue Reading
CrossBay Medical Inc.'s SonoSure(TM) Sonohysterography and Endometrial Sampling Device is indicated for use to access the uterine cavity for saline infusion sonohysterography and to obtain endometrial biopsy, if indicated, utilizing the same device. (PRNewsFoto/CrossBay Medical, Inc.)
CrossBay Medical Inc.'s SonoSure(TM) Sonohysterography and Endometrial Sampling Device is indicated for use to access the uterine cavity for saline infusion sonohysterography and to obtain endometrial biopsy, if indicated, utilizing the same device. (PRNewsFoto/CrossBay Medical, Inc.)
CrossBay Medical, Inc. was founded in 2009 with the goal of providing affordable healthcare products for women and children. The strategic partners in the company have developed, manufactured, registered and commercialized products for a combined 60 years. CrossBay Medical’s products are designed in the United States, manufactured in China, and distributed by an existing network of affiliates. To learn more, visit crossbaymedicalinc.com. (PRNewsFoto/CrossBay Medical, Inc.)
CrossBay Medical, Inc. was founded in 2009 with the goal of providing affordable healthcare products for women and children. The strategic partners in the company have developed, manufactured, registered and commercialized products for a combined 60 years. CrossBay Medical’s products are designed in the United States, manufactured in China, and distributed by an existing network of affiliates. To learn more, visit crossbaymedicalinc.com. (PRNewsFoto/CrossBay Medical, Inc.)

Abnormal Uterine Bleeding (AUB) occurs in 20 percent of women between the ages of 19 to 55.  Saline Infusion Sonohysterography (SIS) and Endometrial Biopsy (EMB) are routinely used in the workup for AUB. Many providers perform these procedures at the same setting, using separate instrumentation for each procedure. This requires cannulation of the cervix at least twice. Other providers may require patients to have separate visits for the procedures. The SonoSure™ device combines Saline Infusion Sonohysterography and Endometrial Biopsy in the same device. 

"We are excited about receiving the clearance for SonoSure™ as we can now provide our affiliate partners in the US, Canada and Europe with a truly affordable and effective product," said Piush Vidyarthi, CEO of CrossBay Medical Inc.  "CrossBay's goal is to continue to develop innovative devices for women and children for the global market.  We have numerous products in development that we plan to bring to market in the near future."

In the US, CrossBay has entered into an exclusive agreement to commercialize the product.  "At Norgenix, it is our goal to offer quality products that provide solutions to the unmet needs within women's health," stated Michael Rackley, COO & Senior Vice President of Norgenix. "We immediately recognized the value that CrossBay Medical's devices may have for Gynecology. With the exclusive rights to market, sell, and distribute the SonoSure™ in the U.S., we look forward to providing such innovations to the healthcare marketplace."

CrossBay Medical, Inc. was founded in 2009 with the goal of providing affordable healthcare products for women and children.  The strategic partners in the company have developed, manufactured, registered and commercialized products for a combined 60 years. CrossBay Medical's products are designed in the United States, manufactured in China, and distributed by an existing network of affiliates.

ABOUT CROSSBAY MEDICAL, INC. | www.crossbaymedicalinc.com
ABOUT NORGENIX | www.norgenixpharma.com

Media Contact:
Sims Bouwmeester, 864.580.2350, [email protected]

Photo - http://photos.prnewswire.com/prnh/20140425/78428 
Logo - http://photos.prnewswire.com/prnh/20140425/78426

SOURCE CrossBay Medical, Inc.

PRN Top Stories Newsletters

Sign up to get PRN’s top stories and curated news delivered to your inbox weekly!

Thank you for subscribing!

By signing up you agree to receive content from us.
Our newsletters contain tracking pixels to help us deliver unique content based on each subscriber's engagement and interests. For more information on how we will use your data to ensure we send you relevant content please visit our PRN Consumer Newsletter Privacy Notice. You can withdraw your consent at any time in the footer of every email you'll receive. Mit Ihrer Anmeldung erklären Sie sich damit einverstanden, Inhalte von uns zu erhalten.
Unsere Newsletter enthalten Zählpixel, die die Lieferung einzigartiger Inhalte in Bezug auf das Abonnement und die Interessen der einzelnen Abonnenten ermöglichen. Weitere Informationen über die Verwendung Ihrer Daten im Hinblick auf die Zusendung von relevanten Inhalten, finden Sie in unserer PRN Consumer Newsletter Privacy Notice. Ihre Zustimmung können Sie jederzeit in der Fußzeile jeder erhaltenen E-Mail widerrufen. En vous inscrivant à la newsletter, vous consentez à la réception de contenus de notre part.
Notre newsletter contient des pixels espions nous permettant la fourniture à chaque abonné, d’un contenu unique en lien avec ses souscriptions et intérêts. Pour de plus amples informations sur l’utilisation faite de vos données en vue de l’envoi des contenus concernés, nous vous invitons à consulter la politique de confidentialité disponible à partir du lien suivant PRN Consumer Newsletter Privacy Notice. Vous pouvez à tout moment revenir sur votre consentement par le biais des informations situées au bas de chaque e-mail reçu. Регистрирайки се, Вие се съгласявате да получавате информационно съдържание от нас. Нашите бюлетини съдържат проследяващи пиксели, които ни помагат да предоставяме уникално съдържание въз основа на ангажираността и интересите на всеки абонат. За повече информация относно начина, по който ще използваме Вашите данни, за да гарантираме, че Ви изпращаме подходящо съдържание, моля, направете справка с нашето Уведомление за поверителност на потребителския бюлетин на PRN. Можете да оттеглите съгласието си по всяко време в долния колонтитул на всеки от имейлите, които ще получите.